SOPH SOPHiA GENETICS SA
$7.87▲ +3.42%
Healthcare
Other
After hours
$7.87▲ +0.00%
Sep 11, 7:30 PM ET
Volume 243.5K
Avg Volume (10D) 583.9K
Key Metrics & Fundamentals
Market Cap
$669.96M
P/E Ratio
–
Div Yield
–%
52W Range
3.10 - 8.98
% vs 50 MA
12.88%
% vs 200 MA
44.44%
RSI-14
51.6
MACD Histogram
-0.1700
Beta (1Y vs SPY)
1.48
Free Cash Flow
-$10.39M
Gross Rev
$23.31M
Gross Profit
$15.06M
EBITDA
-$16.92M
COGS
$8.25M
Operating Exp
$35.11M
Operating Income
-$20.05M
EBIT
-$20.05M
Pretax Income
-$22.28M
Net Income
-$22.36M
EPS (Diluted)
-0.30
Price & Volume History
Loading chart…
Recent News
SOPHiA GENETICS (SOPH) Stock Sees Modest Fair Value Lift After Q2 Guidance Raise
Simply Wall St. · Sep 4, 2026 1:08 PM
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals
MarketBeat · Aug 27, 2026 12:35 PM
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 11, 2026 4:46 PM
AstraZeneca (LSE:AZN) Signs Two Cancer Diagnostics Deals To Widen Patient Access
Simply Wall St. · Aug 8, 2026 3:12 PM
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics
Medical Device Network · Aug 5, 2026 9:45 AM
Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ...
GuruFocus.com · Aug 4, 2026 7:00 PM
SOPHiA GENETICS Q2 Earnings Call Highlights
MarketBeat · Aug 4, 2026 6:04 PM
SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?
Stocktwits · Aug 4, 2026 3:23 PM
AstraZeneca Collaborates With Sophia Genetics on Companion Diagnostics for Oncology Therapies
MT Newswires · Aug 4, 2026 2:07 PM
SOPHiA GENETICS Reports Second Quarter 2026 Results
PR Newswire · Aug 4, 2026 10:45 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See SOPH's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.